Literature DB >> 1323651

A comparison of the discriminative stimulus properties of delta 9-tetrahydrocannabinol and CP 55,940 in rats and rhesus monkeys.

L H Gold1, R L Balster, R L Barrett, D T Britt, B R Martin.   

Abstract

CP 55,940 [(-)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3- hydroxypropyl)cyclohexanol] is a potent bicyclic analog of delta 9-tetrahydrocannabinol (THC) which has been used as a probe for a cannabinoid recognition site in neural tissue. In the present study, CP 55,490 was evaluated for delta 9-THC-like effects in rats and rhesus monkeys trained to discriminate delta 9-THC from vehicle. Rats trained to discriminate delta 9-THC (3.0 mg/kg i.p.) from vehicle were tested with various doses of delta 9-THC and CP 55,940 at both 30 and 90 min postinjection. Catalepsy was measured immediately after these operant tests using an adaptation of the mouse ring-test. In rats, CP 55,940 substituted for delta 9-THC at both 30 and 90 min postinjection at a dose of 0.1 mg/kg that had minimal effects on rates of responding. Doses of delta 9-THC (greater than 3.0 mg/kg) and CP 55,940 (greater than 0.1 mg/kg) that reduced response rates by greater than 50% also produced substantial increases in catalepsy. CP 55,940 and delta 9-THC had a similar time course for discriminative stimulus effects, but CP 55,940 was about 30 times more potent. In monkeys, the training dose of delta 9-THC ranged from 0.04 to 0.16 mg/kg i.m., adjusted individually to minimize response-rate disruption. After training, monkeys were tested with various doses of delta 9-THC and CP 55,940 at 30 min postinjection.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1323651

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  17 in total

1.  Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice.

Authors:  Lance R McMahon; Brett C Ginsburg; R J Lamb
Journal:  Psychopharmacology (Berl)       Date:  2007-08-03       Impact factor: 4.530

2.  Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents.

Authors:  Jenny L Wiley; D Matthew Walentiny; M Jerry Wright; Patrick M Beardsley; James J Burston; Justin L Poklis; Aron H Lichtman; Robert E Vann
Journal:  Eur J Pharmacol       Date:  2014-05-22       Impact factor: 4.432

3.  Dissimilar cannabinoid substitution patterns in mice trained to discriminate Δ(9)-tetrahydrocannabinol or methanandamide from vehicle.

Authors:  Jenny L Wiley; D Matthew Walentiny; Robert E Vann; Cassandra Y Baskfield
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

4.  Enhancement of the behavioral effects of endogenous and exogenous cannabinoid agonists by phenylmethyl sulfonyl fluoride.

Authors:  R E Vann; D M Walentiny; J J Burston; K M Tobey; T F Gamage; J L Wiley
Journal:  Neuropharmacology       Date:  2011-10-31       Impact factor: 5.250

5.  Ovarian hormones and chronic administration during adolescence modify the discriminative stimulus effects of delta-9-tetrahydrocannabinol (Δ⁹-THC) in adult female rats.

Authors:  Peter J Winsauer; Catalin M Filipeanu; Evangeline M Bailey; Jerielle L Hulst; Jessie L Sutton
Journal:  Pharmacol Biochem Behav       Date:  2012-06-15       Impact factor: 3.533

6.  AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice.

Authors:  Jenny L Wiley; Julie A Marusich; Timothy W Lefever; Kateland R Antonazzo; Michael T Wallgren; Ricardo A Cortes; Purvi R Patel; Megan Grabenauer; Katherine N Moore; Brian F Thomas
Journal:  J Pharmacol Exp Ther       Date:  2015-06-23       Impact factor: 4.030

7.  Acute and chronic effects of cannabidiol on Δ⁹-tetrahydrocannabinol (Δ⁹-THC)-induced disruption in stop signal task performance.

Authors:  David S Jacobs; Stephen J Kohut; Shan Jiang; Spyros P Nikas; Alexandros Makriyannis; Jack Bergman
Journal:  Exp Clin Psychopharmacol       Date:  2016-08-15       Impact factor: 3.157

8.  Pharmacological effects of cannabinoids on the reference and working memory functions in mice.

Authors:  Avdesh Avdesh; Yikai Hoe; Ralph N Martins; Mathew T Martin-Iverson
Journal:  Psychopharmacology (Berl)       Date:  2012-08-19       Impact factor: 4.530

9.  Evaluation of cannabinoid agonists using punished responding and midazolam discrimination procedures in squirrel monkeys.

Authors:  Marcus S Delatte; Carol A Paronis
Journal:  Psychopharmacology (Berl)       Date:  2007-09-19       Impact factor: 4.530

10.  Discriminative stimulus functions in rats of AM1346, a high-affinity CB1R selective anandamide analog.

Authors:  Torbjörn U C Järbe; Chen Li; Qian Liu; Alexandros Makriyannis
Journal:  Psychopharmacology (Berl)       Date:  2008-06-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.